Assay News and Research

RSS

Blood test could help gauge psychosis risk

Researchers have developed a multiplex blood assay that may aid the identification of high-risk individuals who will progress to psychosis.

21 Aug 2014

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus.

20 Aug 2014

Cellular Research announces start of early access program for Precise assays

Cellular Research announced today the start of an early access program for its Precise assays and is currently making the product available to 10 sites.

19 Aug 2014

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.

19 Aug 2014

Caris Life Sciences collaborates with GenoSpace to advance cancer care through research

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced a collaboration with GenoSpace, a Massachusetts-based technology company that develops robust software solutions for genomic and health data.

14 Aug 2014

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose.

14 Aug 2014

Researchers develop novel fluorescence-based assay for early detection of diabetes

A team of researchers from the Center for Engineering in Medicine at the Massachusetts General Hospital have developed a novel fluorescence-based assay for sensitive detection of antibodies within microliter volume serum samples.

12 Aug 2014

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today.

12 Aug 2014

Infectious prion protein is marker for variant Creutzfeldt-Jakob disease

The misfolded and infectious prion protein that is a marker for variant Creutzfeldt-Jakob disease - linked to the consumption of infected cattle meat - has been detected in the urine of patients with the disease by researchers at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

8 Aug 2014

UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

Muscle physiologist Edward Debold at the University of Massachusetts Amherst's School of Public Health and Health Sciences recently received a three-year, $198,000 grant from the American Heart Association to support studies to uncover the molecular mechanisms of skeletal muscle fatigue.

7 Aug 2014

New molecular test kit predicts survival outcomes in kidney cancer patients

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.

4 Aug 2014

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.

1 Aug 2014

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.

28 Jul 2014

IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX Laboratories, Inc. today reported that revenues for the second quarter of 2014 increased 11% versus the prior year period to $390 million.

25 Jul 2014

EKF Diagnostics to highlight expanding product portfolio at AACC Clinical Lab Expo

EKF, will be highlighting its expanding product portfolio on its subsidiary Stanbio Laboratory’s booth #1933 at the AACC Clinical Lab Expo in Chicago, USA.

From EKF Diagnostics 24 Jul 2014

Chemclin's HIV kits for in-vitro qualitative determination of Anti-HIV 1+2

Chemclin's HIV kits are available for in-vitro qualitative determination of Antibody to Human Immunodeficiency Virus Type 1 and Type 2 (Anti-HIV 1+2) and P24 antigen of HIV in human serum or plasma by a sandwich chemiluminescent assay method.

22 Jul 2014

Chemclin's Anti-TP assay provides components for in-vitro qualitative determination of Anti-TP

Chemclin's Anti-TP assay provides components for in-vitro qualitative determination of Antibody to Treponema Pallidum (Anti-TP) in human serum or plasma by a double - antigen sandwich chemiluminescent assay method.

22 Jul 2014

Chemclin's Vitamin D assay helps in quantitative determination of 25-OH Vitamin D in human serum

Chemclin's new Vitamin D assay provides components for in-vitro quantitative determination of 25-Hydroxy Vitamin D (25-OH Vitamin D) in human serum by a competitive chemiluminescent assay method.

22 Jul 2014

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.

22 Jul 2014

Randox Cystatin C facilitates early detection and treatment of chronic kidney disease

As a more sensitive maker of renal dysfunction Randox Cystatin C offers several advantages over traditional creatinine assays.

From Randox Laboratories Ltd. 22 Jul 2014

Assay News and Research

Blood test could help gauge psychosis risk

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Cellular Research announces start of early access program for Precise assays

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Caris Life Sciences collaborates with GenoSpace to advance cancer care through research

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

Researchers develop novel fluorescence-based assay for early detection of diabetes

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Infectious prion protein is marker for variant Creutzfeldt-Jakob disease

UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

New molecular test kit predicts survival outcomes in kidney cancer patients

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

IDEXX revenues increase 11% to $390M in second quarter 2014

EKF Diagnostics to highlight expanding product portfolio at AACC Clinical Lab Expo

Chemclin's HIV kits for in-vitro qualitative determination of Anti-HIV 1+2

Chemclin's Anti-TP assay provides components for in-vitro qualitative determination of Anti-TP

Chemclin's Vitamin D assay helps in quantitative determination of 25-OH Vitamin D in human serum

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Randox Cystatin C facilitates early detection and treatment of chronic kidney disease

eBook: Using iPSCs models for human disease research and drug discovery eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News